Malignant Esophageal Neoplasm by Topographic Region

Malignant Esophageal Neoplasm by Topographic Region — Trials · CancerIndex

Clinical trials

Registered studies

9 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 2
Recruiting: 1
Ph III recruiting: 0
Growth YoY: —
Industry share: 0%
Top sponsor: National Cancer Institute (NCI)
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04460937	Testing the Addition of an Anti-cancer Drug, Adavosertib, to Radiation Therapy for Patients With Incurable Esophageal and Gastroesophageal Junction Cancers	active not recruiting	Phase 1	4	National Cancer Institute (NCI)NIH	1	Jul 31, 2026	clinicaltrials
NCT05276791	EMR Versus ESD for Barrett's Neoplasia(REMOVE-RCT)	recruiting	N/A	331	St. Antonius HospitalOTHER	1	Jun 29, 2026